Covalon Technologies Ltd. Announces Second Quarter Financial Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced financial results for its second quarter ended March 31, 2016.
Brian Pedlar, Covalon's President and CEO, stated “As we previously disclosed, delays in the awarding of tenders by the healthcare authorities in Saudi Arabia resulted in Covalon not receiving revenue it expected to receive by the end of the second quarter ending March 31, 2016.
Brian Pedlar, Covalon's President and CEO, stated “As we previously disclosed, delays in the awarding of tenders by the healthcare authorities in Saudi Arabia resulted in Covalon not receiving revenue it expected to receive by the end of the second quarter ending March 31, 2016.